Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Aerosol IL-2 for Pulmonary Metastases
This study is currently recruiting participants.
Verified March 2013
by M.D. Anderson Cancer Center
Study NCT01590069 Information provided by M.D. Anderson Cancer Center
First Received on April 30, 2012. Last Updated on March 4, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sarcoma
Solid Tumors
Pulmonary Metastases
Lung Metastases
Osteosarcomas
Ewing Sarcoma
Additional conditions recognized in this trial
Lung Neoplasms
Neoplasm Metastasis
Neoplasms, Second Primary
Neuroectodermal Tumors, Primitive, Peripheral
Osteosarcoma
Sarcoma, Ewing's
More general conditions related to this trial
Lung Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Bone Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms, Connective Tissue
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neoplastic Processes
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Pathologic Processes
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
Interventions listed in this trial
Aerosol IL-2
Symptom Assessment
Additional drug interventions recognized in this trial
Aldesleukin
Interleukin-2
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antineoplastic Agents
Antiviral Agents
Central Nervous System Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
M.D. Anderson Cancer Center
Shannon Wilkes Foundation
Back to top of Main Content
